Anxiety trials recruiting in Michigan

All Anxiety trials nationally

Cities in Michigan

Recruiting trials in Michigan

• Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
  NCT07123467 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: All (male and female) · Michigan: Detroit
• Evaluating Screening Adherence Between Moment for Parents App and Attention Control
  NCT07322042 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Michigan: Ann Arbor
• Exercise Facilitation of Adolescent Fear Extinction, Frontolimbic Circuitry, and Endocannabinoids
  NCT06297278 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 17 Years · Sex: All (male and female) · Michigan: Detroit
• Family Acceptance Project Online (Pilot RCT)
  NCT06839859 · Phase: Phase 2 · Ages: 14 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Family Spirit Strengths
  NCT05836090 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years and older · Sex: Female · Michigan: Pokagon
• Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental Procedures
  NCT06725134 · Phase: Not applicable (e.g. observational or device study) · Ages: 4 Years to 12 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
  NCT06563310 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 24 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Optimizing Low Vision Rehabilitation in Emotionally Distressed Patients With Inherited Retinal Diseases
  NCT06651736 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
  NCT07002034 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor, Novi
• RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
  NCT07489651 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Michigan: Novi
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
  NCT06480383 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · Michigan: Ann Arbor
• Support for Bereaved Cancer Caregivers
  NCT06662409 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: East Lansing